Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03411291 · ClinicalTrials.gov registry record
Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT03411291: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT03411291 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03411291 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Specific Aim: Demonstrate that statins have an effect on cerebral blood flow and neuronal activity
Primary Outcome
Changes in metabolite concentration in areas of the brain linked to memory measured by MR spectroscopy with quantitative post processing
Interventions
- DEVICE MRI, MR Spectroscopy, MR Perfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-09 |
What the finished NCT03411291 record still lists
NCT03411291 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI, MR Spectroscopy, MR Perfusion is the first listed.
NCT03411291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03411291 about?
NCT03411291 is a clinical study titled "Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study". Specific Aim: Demonstrate that statins have an effect on cerebral blood flow and neuronal activity
What is the current status of trial NCT03411291?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2007-04. Estimated completion is 2010-09.
What interventions are being tested in trial NCT03411291?
The interventions under investigation include: MRI, MR Spectroscopy, MR Perfusion (DEVICE).
Who is sponsoring clinical trial NCT03411291?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia